参考文献

［1］Bray F，Ferlay J，Soerjomataram I，et al.Global cancer statistics 2018：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin，2018，68（6）：394-424.

［2］Strober W，Fuss I J.Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases［J］.Gastroenterology，2011，140（6）：1756-1767.

［3］Dong C.TH17 cells in development：an updated view of their molecular identity and genetic programming［J］.Nat Rev Immunol，2008，8（5）：337-348.

［4］Reiner S L.Development in motion：helper T cells at work［J］.Cell，2007，129（1）：33-36.

［5］Abraham C，Medzhitov R.Interactions between the host innate immune system and microbes in inflammatory bowel disease［J］.Gastroenterology，2011，140（6）：1729-1737.

［6］Morrison P J，Ballantyne S J，Kullberg M C.Interleukin-23 and T helper 17-type responses in intestinal inflammation：from cytokines to T-cell plasticity［J］.Immunology，2011，133（4）：397-408.(https://www.daowen.com)

［7］Acosta-Rodriguez E V，Napolitani G，Lanzavecchia A，et al.Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells［J］.Nat Immunol，2007，8（9）：942-949.

［8］Das J，Ren G W，Zhang L Y，et al.Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation［J］.J Exp Med，2009，206（11）：2407-2416.

［9］Erreni M，Mantovani A，Allavena P，et al.Tumorassociated macrophages（TAM）and inflammation in colorectal cancer［J］.Cancer Microenviron，2011，4（2）：141-154.

［10］Manel N，Unutmaz D，Littman D R.The differentiation of human T（H）-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat［J］.Nat Immunol，2008，9（6）：641-649.

［11］Liu J K，Duan Y Z，Cheng X M，et al.IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma［J］.Biochem Biophys Res Commun，2011，407（2）：348-354.